moreView todays social media effects on ARNAView the latest stocks trending across Twitter. Click to view dashboardSee who Arena is hiring next, click here to view […]
[PR Newswire] – SAN DIEGO, Feb. 12, 2014 /PRNewswire/ — Arena Pharmaceuticals, Inc. (ARNA) announced today that Eisai Laboratorios Ltda., a subsidiary of Eisai Inc., has filed for marketing authorization of BELVIQ® as a treatment for chronic weight man moreView todays social media effects on ARNAView the latest stocks trending across Twitter. Click to view dashboardSee who Arena is hiring […]
moreView todays social media effects on ARNAView the latest stocks trending across Twitter. Click to view dashboardSee who Arena is hiring next, click here to view […]
moreView todays social media effects on ARNAView the latest stocks trending across Twitter. Click to view dashboardSee who Arena is hiring next, click here to view […]
[ACN Newswire] – By Jake KingOrexigen Therapeutics (NASDAQ:OREX) will be releasing its third quarter earnings report after the market’s close Wednesday night, and with all of the hoopla surrounding obesity drugs Qsymia … moreView todays social media effects on ARNAView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingWord from Orexigen Therapeutics (NASDAQ:OREX) Wednesday that it will be raising capital in the form of an equity offering came as little surprise to investors, and the market is taking the … moreView todays social media effects on ARNAView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingThe competition among obesity-drug makers continues to heat up Monday following an announcement from OrexigenTherapeutics (NASDAQ:OREX) that the company may be able to expedite the approval … moreView todays social media effects on ARNAView the latest stocks trending across Twitter. Click to view dashboard […]
